Open0.449 | Close0.492 |
Vol / Avg.1.024M / 178.872K | Mkt Cap2.102M |
Day Range0.449 - 0.550 | 52 Wk Range0.360 - 1.730 |
Histogen Stock (NASDAQ: HSTO) stock price, news, charts, stock research, profile.
Open0.449 | Close0.492 |
Vol / Avg.1.024M / 178.872K | Mkt Cap2.102M |
Day Range0.449 - 0.550 | 52 Wk Range0.360 - 1.730 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | ||||||
REV | 5.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-03-29 | HC Wainwright & Co. | Douglas Tsao | Maintains | Buy | Lowers | 2.40 | 1.50 |
2021-08-30 | HC Wainwright & Co. | Douglas Tsao | Initiates Coverage On | Buy | Announces | - | 2.40 |
2021-06-04 | Canaccord Genuity | - | Maintains | Buy | Lowers | 5.00 | 4.00 |
2021-03-04 | Canaccord Genuity | - | Initiates Coverage On | Buy | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSTO | Histogen | -1.6% | 2.1M |
PSTV | Plus Therapeutics | -1.59% | 3.6M |
DRMA | Dermata Therapeutics | -3.57% | 3.4M |
NBSE | NeuBase Therapeutics | -7.34% | 3.1M |
BBLG | Bone Biologics | 0% | 2.4M |
You can purchase shares of Histogen (NASDAQ: HSTO) through any online brokerage.
Other companies in Histogen’s space includes: Plus Therapeutics (NASDAQ:PSTV), Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG) and Synaptogenix (NASDAQ:SNPX).
The latest price target for Histogen (NASDAQ: HSTO) was reported by HC Wainwright & Co. on Tuesday, March 29, 2022. The analyst firm set a price target for 1.50 expecting HSTO to rise to within 12 months (a possible 204.88% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Histogen (NASDAQ: HSTO) is $0.492 last updated Today at September 21, 2023 at 8:00 PM UTC.
There is no dividend information for Histogen.
Histogen’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Histogen.
Histogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Histogen Stock (NASDAQ: HSTO) stock price, news, charts, stock research, profile.
Open0.449 | Close0.492 |
Vol / Avg.1.024M / 178.872K | Mkt Cap2.102M |
Day Range0.449 - 0.550 | 52 Wk Range0.360 - 1.730 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | ||||||
REV | 5.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-03-29 | HC Wainwright & Co. | Douglas Tsao | Maintains | Buy | Lowers | 2.40 | 1.50 |
2021-08-30 | HC Wainwright & Co. | Douglas Tsao | Initiates Coverage On | Buy | Announces | - | 2.40 |
2021-06-04 | Canaccord Genuity | - | Maintains | Buy | Lowers | 5.00 | 4.00 |
2021-03-04 | Canaccord Genuity | - | Initiates Coverage On | Buy | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSTO | Histogen | -1.6% | 2.1M |
PSTV | Plus Therapeutics | -1.59% | 3.6M |
DRMA | Dermata Therapeutics | -3.57% | 3.4M |
NBSE | NeuBase Therapeutics | -7.34% | 3.1M |
BBLG | Bone Biologics | 0% | 2.4M |
You can purchase shares of Histogen (NASDAQ: HSTO) through any online brokerage.
Other companies in Histogen’s space includes: Plus Therapeutics (NASDAQ:PSTV), Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG) and Synaptogenix (NASDAQ:SNPX).
The latest price target for Histogen (NASDAQ: HSTO) was reported by HC Wainwright & Co. on Tuesday, March 29, 2022. The analyst firm set a price target for 1.50 expecting HSTO to rise to within 12 months (a possible 204.88% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Histogen (NASDAQ: HSTO) is $0.492 last updated Today at September 21, 2023 at 8:00 PM UTC.
There is no dividend information for Histogen.
Histogen’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Histogen.
Histogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Histogen Stock (NASDAQ: HSTO) stock price, news, charts, stock research, profile.
Open0.449 | Close0.492 |
Vol / Avg.1.024M / 178.872K | Mkt Cap2.102M |
Day Range0.449 - 0.550 | 52 Wk Range0.360 - 1.730 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | ||||||
REV | 5.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-03-29 | HC Wainwright & Co. | Douglas Tsao | Maintains | Buy | Lowers | 2.40 | 1.50 |
2021-08-30 | HC Wainwright & Co. | Douglas Tsao | Initiates Coverage On | Buy | Announces | - | 2.40 |
2021-06-04 | Canaccord Genuity | - | Maintains | Buy | Lowers | 5.00 | 4.00 |
2021-03-04 | Canaccord Genuity | - | Initiates Coverage On | Buy | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSTO | Histogen | -1.6% | 2.1M |
PSTV | Plus Therapeutics | -1.59% | 3.6M |
DRMA | Dermata Therapeutics | -3.57% | 3.4M |
NBSE | NeuBase Therapeutics | -7.34% | 3.1M |
BBLG | Bone Biologics | 0% | 2.4M |
You can purchase shares of Histogen (NASDAQ: HSTO) through any online brokerage.
Other companies in Histogen’s space includes: Plus Therapeutics (NASDAQ:PSTV), Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG) and Synaptogenix (NASDAQ:SNPX).
The latest price target for Histogen (NASDAQ: HSTO) was reported by HC Wainwright & Co. on Tuesday, March 29, 2022. The analyst firm set a price target for 1.50 expecting HSTO to rise to within 12 months (a possible 204.88% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Histogen (NASDAQ: HSTO) is $0.492 last updated Today at September 21, 2023 at 8:00 PM UTC.
There is no dividend information for Histogen.
Histogen’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Histogen.
Histogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Histogen Stock (NASDAQ: HSTO) stock price, news, charts, stock research, profile.
Open0.449 | Close0.492 |
Vol / Avg.1.024M / 178.872K | Mkt Cap2.102M |
Day Range0.449 - 0.550 | 52 Wk Range0.360 - 1.730 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | ||||||
REV | 5.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-03-29 | HC Wainwright & Co. | Douglas Tsao | Maintains | Buy | Lowers | 2.40 | 1.50 |
2021-08-30 | HC Wainwright & Co. | Douglas Tsao | Initiates Coverage On | Buy | Announces | - | 2.40 |
2021-06-04 | Canaccord Genuity | - | Maintains | Buy | Lowers | 5.00 | 4.00 |
2021-03-04 | Canaccord Genuity | - | Initiates Coverage On | Buy | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSTO | Histogen | -1.6% | 2.1M |
PSTV | Plus Therapeutics | -1.59% | 3.6M |
DRMA | Dermata Therapeutics | -3.57% | 3.4M |
NBSE | NeuBase Therapeutics | -7.34% | 3.1M |
BBLG | Bone Biologics | 0% | 2.4M |
You can purchase shares of Histogen (NASDAQ: HSTO) through any online brokerage.
Other companies in Histogen’s space includes: Plus Therapeutics (NASDAQ:PSTV), Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG) and Synaptogenix (NASDAQ:SNPX).
The latest price target for Histogen (NASDAQ: HSTO) was reported by HC Wainwright & Co. on Tuesday, March 29, 2022. The analyst firm set a price target for 1.50 expecting HSTO to rise to within 12 months (a possible 204.88% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Histogen (NASDAQ: HSTO) is $0.492 last updated Today at September 21, 2023 at 8:00 PM UTC.
There is no dividend information for Histogen.
Histogen’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Histogen.
Histogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Histogen Stock (NASDAQ: HSTO) stock price, news, charts, stock research, profile.
Open0.449 | Close0.492 |
Vol / Avg.1.024M / 178.872K | Mkt Cap2.102M |
Day Range0.449 - 0.550 | 52 Wk Range0.360 - 1.730 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | ||||||
REV | 5.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-03-29 | HC Wainwright & Co. | Douglas Tsao | Maintains | Buy | Lowers | 2.40 | 1.50 |
2021-08-30 | HC Wainwright & Co. | Douglas Tsao | Initiates Coverage On | Buy | Announces | - | 2.40 |
2021-06-04 | Canaccord Genuity | - | Maintains | Buy | Lowers | 5.00 | 4.00 |
2021-03-04 | Canaccord Genuity | - | Initiates Coverage On | Buy | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSTO | Histogen | -1.6% | 2.1M |
PSTV | Plus Therapeutics | -1.59% | 3.6M |
DRMA | Dermata Therapeutics | -3.57% | 3.4M |
NBSE | NeuBase Therapeutics | -7.34% | 3.1M |
BBLG | Bone Biologics | 0% | 2.4M |
You can purchase shares of Histogen (NASDAQ: HSTO) through any online brokerage.
Other companies in Histogen’s space includes: Plus Therapeutics (NASDAQ:PSTV), Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG) and Synaptogenix (NASDAQ:SNPX).
The latest price target for Histogen (NASDAQ: HSTO) was reported by HC Wainwright & Co. on Tuesday, March 29, 2022. The analyst firm set a price target for 1.50 expecting HSTO to rise to within 12 months (a possible 204.88% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Histogen (NASDAQ: HSTO) is $0.492 last updated Today at September 21, 2023 at 8:00 PM UTC.
There is no dividend information for Histogen.
Histogen’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Histogen.
Histogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Histogen Stock (NASDAQ: HSTO) stock price, news, charts, stock research, profile.
Open0.449 | Close0.492 |
Vol / Avg.1.024M / 178.872K | Mkt Cap2.102M |
Day Range0.449 - 0.550 | 52 Wk Range0.360 - 1.730 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | ||||||
REV | 5.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-03-29 | HC Wainwright & Co. | Douglas Tsao | Maintains | Buy | Lowers | 2.40 | 1.50 |
2021-08-30 | HC Wainwright & Co. | Douglas Tsao | Initiates Coverage On | Buy | Announces | - | 2.40 |
2021-06-04 | Canaccord Genuity | - | Maintains | Buy | Lowers | 5.00 | 4.00 |
2021-03-04 | Canaccord Genuity | - | Initiates Coverage On | Buy | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSTO | Histogen | -1.6% | 2.1M |
PSTV | Plus Therapeutics | -1.59% | 3.6M |
DRMA | Dermata Therapeutics | -3.57% | 3.4M |
NBSE | NeuBase Therapeutics | -7.34% | 3.1M |
BBLG | Bone Biologics | 0% | 2.4M |
You can purchase shares of Histogen (NASDAQ: HSTO) through any online brokerage.
Other companies in Histogen’s space includes: Plus Therapeutics (NASDAQ:PSTV), Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG) and Synaptogenix (NASDAQ:SNPX).
The latest price target for Histogen (NASDAQ: HSTO) was reported by HC Wainwright & Co. on Tuesday, March 29, 2022. The analyst firm set a price target for 1.50 expecting HSTO to rise to within 12 months (a possible 204.88% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Histogen (NASDAQ: HSTO) is $0.492 last updated Today at September 21, 2023 at 8:00 PM UTC.
There is no dividend information for Histogen.
Histogen’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Histogen.
Histogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Histogen Stock (NASDAQ: HSTO) stock price, news, charts, stock research, profile.
Open0.449 | Close0.492 |
Vol / Avg.1.024M / 178.872K | Mkt Cap2.102M |
Day Range0.449 - 0.550 | 52 Wk Range0.360 - 1.730 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | ||||||
REV | 5.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-03-29 | HC Wainwright & Co. | Douglas Tsao | Maintains | Buy | Lowers | 2.40 | 1.50 |
2021-08-30 | HC Wainwright & Co. | Douglas Tsao | Initiates Coverage On | Buy | Announces | - | 2.40 |
2021-06-04 | Canaccord Genuity | - | Maintains | Buy | Lowers | 5.00 | 4.00 |
2021-03-04 | Canaccord Genuity | - | Initiates Coverage On | Buy | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSTO | Histogen | -1.6% | 2.1M |
PSTV | Plus Therapeutics | -1.59% | 3.6M |
DRMA | Dermata Therapeutics | -3.57% | 3.4M |
NBSE | NeuBase Therapeutics | -7.34% | 3.1M |
BBLG | Bone Biologics | 0% | 2.4M |
You can purchase shares of Histogen (NASDAQ: HSTO) through any online brokerage.
Other companies in Histogen’s space includes: Plus Therapeutics (NASDAQ:PSTV), Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG) and Synaptogenix (NASDAQ:SNPX).
The latest price target for Histogen (NASDAQ: HSTO) was reported by HC Wainwright & Co. on Tuesday, March 29, 2022. The analyst firm set a price target for 1.50 expecting HSTO to rise to within 12 months (a possible 204.88% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Histogen (NASDAQ: HSTO) is $0.492 last updated Today at September 21, 2023 at 8:00 PM UTC.
There is no dividend information for Histogen.
Histogen’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Histogen.
Histogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Histogen Stock (NASDAQ: HSTO) stock price, news, charts, stock research, profile.
Open0.449 | Close0.492 |
Vol / Avg.1.024M / 178.872K | Mkt Cap2.102M |
Day Range0.449 - 0.550 | 52 Wk Range0.360 - 1.730 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | ||||||
REV | 5.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-03-29 | HC Wainwright & Co. | Douglas Tsao | Maintains | Buy | Lowers | 2.40 | 1.50 |
2021-08-30 | HC Wainwright & Co. | Douglas Tsao | Initiates Coverage On | Buy | Announces | - | 2.40 |
2021-06-04 | Canaccord Genuity | - | Maintains | Buy | Lowers | 5.00 | 4.00 |
2021-03-04 | Canaccord Genuity | - | Initiates Coverage On | Buy | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSTO | Histogen | -1.6% | 2.1M |
PSTV | Plus Therapeutics | -1.59% | 3.6M |
DRMA | Dermata Therapeutics | -3.57% | 3.4M |
NBSE | NeuBase Therapeutics | -7.34% | 3.1M |
BBLG | Bone Biologics | 0% | 2.4M |
You can purchase shares of Histogen (NASDAQ: HSTO) through any online brokerage.
Other companies in Histogen’s space includes: Plus Therapeutics (NASDAQ:PSTV), Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG) and Synaptogenix (NASDAQ:SNPX).
The latest price target for Histogen (NASDAQ: HSTO) was reported by HC Wainwright & Co. on Tuesday, March 29, 2022. The analyst firm set a price target for 1.50 expecting HSTO to rise to within 12 months (a possible 204.88% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Histogen (NASDAQ: HSTO) is $0.492 last updated Today at September 21, 2023 at 8:00 PM UTC.
There is no dividend information for Histogen.
Histogen’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Histogen.
Histogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Histogen Stock (NASDAQ: HSTO) stock price, news, charts, stock research, profile.
Open0.449 | Close0.492 |
Vol / Avg.1.024M / 178.872K | Mkt Cap2.102M |
Day Range0.449 - 0.550 | 52 Wk Range0.360 - 1.730 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | ||||||
REV | 5.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-03-29 | HC Wainwright & Co. | Douglas Tsao | Maintains | Buy | Lowers | 2.40 | 1.50 |
2021-08-30 | HC Wainwright & Co. | Douglas Tsao | Initiates Coverage On | Buy | Announces | - | 2.40 |
2021-06-04 | Canaccord Genuity | - | Maintains | Buy | Lowers | 5.00 | 4.00 |
2021-03-04 | Canaccord Genuity | - | Initiates Coverage On | Buy | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSTO | Histogen | -1.6% | 2.1M |
PSTV | Plus Therapeutics | -1.59% | 3.6M |
DRMA | Dermata Therapeutics | -3.57% | 3.4M |
NBSE | NeuBase Therapeutics | -7.34% | 3.1M |
BBLG | Bone Biologics | 0% | 2.4M |
You can purchase shares of Histogen (NASDAQ: HSTO) through any online brokerage.
Other companies in Histogen’s space includes: Plus Therapeutics (NASDAQ:PSTV), Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG) and Synaptogenix (NASDAQ:SNPX).
The latest price target for Histogen (NASDAQ: HSTO) was reported by HC Wainwright & Co. on Tuesday, March 29, 2022. The analyst firm set a price target for 1.50 expecting HSTO to rise to within 12 months (a possible 204.88% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Histogen (NASDAQ: HSTO) is $0.492 last updated Today at September 21, 2023 at 8:00 PM UTC.
There is no dividend information for Histogen.
Histogen’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Histogen.
Histogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.